Browse by Changes
Summary of Changes – 1 December 2025
Page last updated: 1 December 2025
Previous versions of the Summary of Changes are available in PDF in the Publications Archive.
- Prescriber Bag
- Additions
- Deletions
- Alterations
- Supply Only
- Advance Notices
- Palliative Care
- Highly Specialised Drugs Program (Private Hospital)
- Highly Specialised Drugs Program (Public Hospital)
- Highly Specialised Drugs Program (Community Access)
- IVF Program
- Repatriation Pharmaceutical Benefits
- Efficient Funding of Chemotherapy (Private Hospital)
- Efficient Funding of Chemotherapy (Public Hospital)
- Related Pharmaceutical Benefits for Public Hospital use
Prescriber Bag
Additions
Addition – Brand
| 3456X | HALOPERIDOL MEDSURGE, DZ – HALOPERIDOL, haloperidol 5 mg/mL injection, 10 x 1 mL ampoules |
Addition – Equivalence Indicator
| 3456X | Serenace, AS – HALOPERIDOL, haloperidol 5 mg/mL injection, 10 x 1 mL ampoules |
Deletions
Deletion – Item
| 3488N | PROMETHAZINE, promethazine hydrochloride 50 mg/2 mL injection, 5 x 2 mL ampoules (DBL Promethazine Hydrochloride) |
Alterations
Alteration – Authorised Prescriber
| From | To | ||
| 3451P | ADRENALINE (EPINEPHRINE), adrenaline (epinephrine) 1 in 1000 (1 mg/mL) injection, 5 x 1 mL ampoules (Link Medical Products Pty Ltd) | M,N | M,N,W |
| 11755Q | BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin tetrahydrate 1.2 million units (1016.6 mg)/2.3 mL injection, 10 x 2.3 mL syringes (Bicillin L-A) | M,N | M,N,W |
| 15053G | BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin 1.2 million units powder for injection [1 vial] (&) inert substance diluent [4 mL ampoule], 1 pack (Lentocilin S 1200 (Portugal)) | M,N | M,N,W |
| 13801J | BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin 1.2 million units powder for injection [1 vial] (&) inert substance diluent [5 mL vial], 1 pack (Extencilline Benzathine Benzylpenicillin (France)) | M,N | M,N,W |
Advance Notices
1 January 2026
Deletion – Brand
| 13801J | Extencilline Benzathine Benzylpenicillin (France), YO – BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin 1.2 million units powder for injection [1 vial] (&) inert substance diluent [5 mL vial], 1 pack |
General Pharmaceutical Benefits
Additions
Addition – Item
| 15118Q | APOMORPHINE, Apomorphine hydrochloride hemihydrate 100 mg/20 mL injection, 5 x 20 mL cartridges (MOVAPO POD) |
| 15121W | APOMORPHINE, Apomorphine hydrochloride hemihydrate 100 mg/20 mL injection, 5 x 20 mL cartridges (MOVAPO POD) |
| 15110G | BIMEKIZUMAB, bimekizumab 160 mg/mL injection, 2 x 1 mL pen devices (Bimzelx) |
| 15116N | BIMEKIZUMAB, bimekizumab 160 mg/mL injection, 2 x 1 mL pen devices (Bimzelx) |
| 15133L | BIMEKIZUMAB, bimekizumab 160 mg/mL injection, 2 x 1 mL pen devices (Bimzelx) |
| 15112J | BIMEKIZUMAB, bimekizumab 320 mg/2 mL injection, 2 mL pen devices (Bimzelx) |
| 15119R | BIMEKIZUMAB, bimekizumab 320 mg/2 mL injection, 2 mL pen devices (Bimzelx) |
| 15131J | BIMEKIZUMAB, bimekizumab 320 mg/2 mL injection, 2 mL pen devices (Bimzelx) |
| 15124B | CABOZANTINIB, cabozantinib 20 mg tablet, 30 (Cabometyx) |
| 15130H | CABOZANTINIB, cabozantinib 20 mg tablet, 30 (Cabometyx) |
| 15114L | CABOZANTINIB, cabozantinib 40 mg tablet, 30 (Cabometyx) |
| 15129G | CABOZANTINIB, cabozantinib 40 mg tablet, 30 (Cabometyx) |
| 15115M | CABOZANTINIB, cabozantinib 60 mg tablet, 30 (Cabometyx) |
| 15123Y | CABOZANTINIB, cabozantinib 60 mg tablet, 30 (Cabometyx) |
| 8740B | FOLINIC ACID, folinic acid 50 mg/5 mL injection, 5 mL vial (DBL Leucovorin Calcium) |
Addition – Brand
| 2698B | ARX-ABIRATERONE, XT – ABIRATERONE, abiraterone acetate 250 mg tablet, 120 |
| 2698B | Abiraterone Dr.Reddy's, RZ – ABIRATERONE, abiraterone acetate 250 mg tablet, 120 |
| 11206T | ARX-ABIRATERONE, XT – ABIRATERONE, abiraterone acetate 500 mg tablet, 60 |
| 10241B | Desvenlafaxine Viatris, AL – DESVENLAFAXINE, desvenlafaxine 50 mg modified release tablet, 28 |
| 14383B | Desvenlafaxine Viatris, AL – DESVENLAFAXINE, desvenlafaxine 50 mg modified release tablet, 28 |
| 10781K | Blooms The Chemist Doxycycline, BG – DOXYCYCLINE, doxycycline 100 mg tablet, 7 |
| 14511R | Blooms The Chemist Doxycycline, BG – DOXYCYCLINE, doxycycline 100 mg tablet, 7 |
| 5082L | Blooms The Chemist Doxycycline, BG – DOXYCYCLINE, doxycycline 100 mg tablet, 7 |
| 9105F | Blooms The Chemist Doxycycline, BG – DOXYCYCLINE, doxycycline 100 mg tablet, 7 |
| 9107H | Blooms The Chemist Doxycycline, BG – DOXYCYCLINE, doxycycline 100 mg tablet, 7 |
| 9108J | Blooms The Chemist Doxycycline, BG – DOXYCYCLINE, doxycycline 100 mg tablet, 7 |
| 14791L | Lucinda, GQ – DROSPIRENONE, drospirenone 4 mg tablet [24] (&) inert substance tablet [4], 4 x 28 |
| 14875X | Lucinda, GQ – DROSPIRENONE, drospirenone 4 mg tablet [24] (&) inert substance tablet [4], 28 |
| 9155W | DULOXETINE-WGR, WG – DULOXETINE, duloxetine 30 mg enteric capsule, 28 |
| 14712H | DULOXETINE-WGR, WG – DULOXETINE, duloxetine 60 mg enteric capsule, 28 |
| 9156X | DULOXETINE-WGR, WG – DULOXETINE, duloxetine 60 mg enteric capsule, 28 |
| 2768Q | HALOPERIDOL MEDSURGE, DZ – HALOPERIDOL, haloperidol 5 mg/mL injection, 10 x 1 mL ampoules |
| 13579Q | ARX-MOXONIDINE, TY – MOXONIDINE, moxonidine 200 microgram tablet, 30 |
| 9019Q | ARX-MOXONIDINE, TY – MOXONIDINE, moxonidine 200 microgram tablet, 30 |
| 8233H | ONDANSETRON-AFT, AE – ONDANSETRON, ondansetron 4 mg/5 mL oral liquid, 50 mL |
| 9441X | ONDANSETRON-AFT, AE – ONDANSETRON, ondansetron 4 mg/5 mL oral liquid, 50 mL |
| 10042M | Pazopanib ADVZ, BZ – PAZOPANIB, pazopanib 200 mg tablet, 90 |
| 10047T | Pazopanib ADVZ, BZ – PAZOPANIB, pazopanib 200 mg tablet, 90 |
| 10054E | Pazopanib ADVZ, BZ – PAZOPANIB, pazopanib 200 mg tablet, 30 |
| 11252F | Pazopanib ADVZ, BZ – PAZOPANIB, pazopanib 200 mg tablet, 90 |
| 2029T | Pazopanib ADVZ, BZ – PAZOPANIB, pazopanib 200 mg tablet, 90 |
| 2232L | Pazopanib ADVZ, BZ – PAZOPANIB, pazopanib 200 mg tablet, 30 |
| 10041L | Pazopanib ADVZ, BZ – PAZOPANIB, pazopanib 400 mg tablet, 60 |
| 10043N | Pazopanib ADVZ, BZ – PAZOPANIB, pazopanib 400 mg tablet, 60 |
| 10052C | Pazopanib ADVZ, BZ – PAZOPANIB, pazopanib 400 mg tablet, 30 |
| 11261Q | Pazopanib ADVZ, BZ – PAZOPANIB, pazopanib 400 mg tablet, 60 |
| 2030W | Pazopanib ADVZ, BZ – PAZOPANIB, pazopanib 400 mg tablet, 60 |
| 2201W | Pazopanib ADVZ, BZ – PAZOPANIB, pazopanib 400 mg tablet, 30 |
| 11123K | Sacubitril/Valsartan Lupin 24/26, GQ – SACUBITRIL + VALSARTAN, sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 |
| 13570F | Sacubitril/Valsartan Lupin 24/26, GQ – SACUBITRIL + VALSARTAN, sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 |
| 11131W | Sacubitril/Valsartan Lupin 49/51, GQ – SACUBITRIL + VALSARTAN, sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 |
| 13511D | Sacubitril/Valsartan Lupin 49/51, GQ – SACUBITRIL + VALSARTAN, sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 |
| 11122J | Sacubitril/Valsartan Lupin 97/103, GQ – SACUBITRIL + VALSARTAN, sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 |
| 13445P | Sacubitril/Valsartan Lupin 97/103, GQ – SACUBITRIL + VALSARTAN, sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 |
| 14401Y | TRANYLMED, DZ – TRANYLCYPROMINE, tranylcypromine 10 mg tablet, 50 |
| 2444P | TRANYLMED, DZ – TRANYLCYPROMINE, tranylcypromine 10 mg tablet, 50 |
| 14472Q | BTC Venlafaxine XR, BG – VENLAFAXINE, venlafaxine 75 mg modified release capsule, 28 |
| 8301X | BTC Venlafaxine XR, BG – VENLAFAXINE, venlafaxine 75 mg modified release capsule, 28 |
| 14402B | BTC Venlafaxine XR, BG – VENLAFAXINE, venlafaxine 150 mg modified release capsule, 28 |
| 8302Y | BTC Venlafaxine XR, BG – VENLAFAXINE, venlafaxine 150 mg modified release capsule, 28 |
Addition – Equivalence Indicator
| 1610R | Leucovorin Calcium (Pfizer Australia Pty Ltd), PF – FOLINIC ACID, folinic acid 50 mg/5 mL injection, 10 x 5 mL ampoules |
| 2768Q | Serenace, AS – HALOPERIDOL, haloperidol 5 mg/mL injection, 10 x 1 mL ampoules |
| 8233H | Zofran syrup 50 mL, AS – ONDANSETRON, ondansetron 4 mg/5 mL oral liquid, 50 mL |
| 9441X | Zofran syrup 50 mL, AS – ONDANSETRON, ondansetron 4 mg/5 mL oral liquid, 50 mL |
| 10042M | Votrient, NV – PAZOPANIB, pazopanib 200 mg tablet, 90 |
| 10047T | Votrient, NV – PAZOPANIB, pazopanib 200 mg tablet, 90 |
| 10054E | Votrient, NV – PAZOPANIB, pazopanib 200 mg tablet, 30 |
| 11252F | Votrient, NV – PAZOPANIB, pazopanib 200 mg tablet, 90 |
| 2029T | Votrient, NV – PAZOPANIB, pazopanib 200 mg tablet, 90 |
| 2232L | Votrient, NV – PAZOPANIB, pazopanib 200 mg tablet, 30 |
| 10041L | Votrient, NV – PAZOPANIB, pazopanib 400 mg tablet, 60 |
| 10043N | Votrient, NV – PAZOPANIB, pazopanib 400 mg tablet, 60 |
| 10052C | Votrient, NV – PAZOPANIB, pazopanib 400 mg tablet, 30 |
| 11261Q | Votrient, NV – PAZOPANIB, pazopanib 400 mg tablet, 60 |
| 2030W | Votrient, NV – PAZOPANIB, pazopanib 400 mg tablet, 60 |
| 2201W | Votrient, NV – PAZOPANIB, pazopanib 400 mg tablet, 30 |
| 14401Y | Parnate, GH – TRANYLCYPROMINE, tranylcypromine 10 mg tablet, 50 |
| 2444P | Parnate, GH – TRANYLCYPROMINE, tranylcypromine 10 mg tablet, 50 |
Addition – Note
| 10131F | EVEROLIMUS, everolimus 5 mg tablet, 30 (Afinitor) |
| 11362B | EVEROLIMUS, everolimus 5 mg tablet, 30 (Afinitor) |
| 10135K | EVEROLIMUS, everolimus 10 mg tablet, 30 (Afinitor) |
| 11377T | EVEROLIMUS, everolimus 10 mg tablet, 30 (Afinitor) |
| 1610R | FOLINIC ACID, folinic acid 50 mg/5 mL injection, 10 x 5 mL ampoules (Leucovorin Calcium (Pfizer Australia Pty Ltd)) |
| 10004M | SUNITINIB, sunitinib 12.5 mg capsule, 28 (Sunitinib Sandoz, Sutent) |
| 2959R | SUNITINIB, sunitinib 25 mg capsule, 28 (ARX-Sunitinib, Sunitinib Sandoz, Sutent) |
| 10464R | SUNITINIB, sunitinib 37.5 mg capsule, 28 (ARX-Sunitinib, Sunitinib Sandoz, Sutent) |
| 2837H | SUNITINIB, sunitinib 50 mg capsule, 28 (ARX-Sunitinib, Sunitinib Sandoz, Sutent) |
Deletions
Deletion – Item
| 1525G | FLUCLOXACILLIN, flucloxacillin 1 g injection, 5 vials (Flucil) |
| 5095E | FLUCLOXACILLIN, flucloxacillin 1 g injection, 5 vials (Fluci |
Deletion – Brand
| 10399H | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 10412B | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 10419J | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 10944B | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 10960W | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 12325Q | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 12326R | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 12327T | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 12331B | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 12333D | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 12365T | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 12366W | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 12367X | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 12387Y | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 12416L | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 12434K | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 12437N | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 12438P | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 13721E | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 13722F | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 13744J | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 14222M | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 14243P | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 14251C | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 14283R | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 14958G | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 15008X | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 15020M | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 5281Y | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 5283C | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 8737W | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 8741C | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 8963R | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 8964T | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 9033K | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 9034L | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 9077R | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 9078T | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 9188N | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 9189P | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 9425C | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 9427E | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 9318K | Pradaxa, BY – DABIGATRAN, dabigatran etexilate 75 mg capsule, 10 |
| 9322P | Pradaxa, BY – DABIGATRAN, dabigatran etexilate 75 mg capsule, 10 |
| 10014C | Erlotinib APOTEX, TX – ERLOTINIB, erlotinib 150 mg tablet, 30 |
| 10025P | Erlotinib APOTEX, TX – ERLOTINIB, erlotinib 150 mg tablet, 30 |
| 11259N | Erlotinib APOTEX, TX – ERLOTINIB, erlotinib 150 mg tablet, 30 |
| 1434L | Fluoxetine APOTEX, TY – FLUOXETINE, fluoxetine 20 mg capsule, 28 |
| 14548Q | Fluoxetine APOTEX, TY – FLUOXETINE, fluoxetine 20 mg capsule, 28 |
| 14408H | Molaxole, XT – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets |
| 8612G | Molaxole, XT – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets |
| 13943W | Olmesartan/Amlodipine 40/10 APOTEX, TX – OLMESARTAN + AMLODIPINE, olmesartan medoxomil 40 mg + amlodipine 10 mg tablet, 30 |
| 5294P | Olmesartan/Amlodipine 40/10 APOTEX, TX – OLMESARTAN + AMLODIPINE, olmesartan medoxomil 40 mg + amlodipine 10 mg tablet, 30 |
| 14057W | APOTEX-Pioglitazone, TX – PIOGLITAZONE, pioglitazone 45 mg tablet, 28 |
| 8696Q | APOTEX-Pioglitazone, TX – PIOGLITAZONE, pioglitazone 45 mg tablet, 28 |
| 14502G | Pariet, JC – RABEPRAZOLE, rabeprazole sodium 10 mg enteric tablet, 28 |
| 8507R | Pariet, JC – RABEPRAZOLE, rabeprazole sodium 10 mg enteric tablet, 28 |
| 11670F | Pariet, JC – RABEPRAZOLE, rabeprazole sodium 20 mg enteric tablet, 30 |
| 12286P | Pariet, JC – RABEPRAZOLE, rabeprazole sodium 20 mg enteric tablet, 30 |
| 14396Q | Pariet, JC – RABEPRAZOLE, rabeprazole sodium 20 mg enteric tablet, 30 |
| 14433P | Pariet, JC – RABEPRAZOLE, rabeprazole sodium 20 mg enteric tablet, 30 |
| 14463F | Pariet, JC – RABEPRAZOLE, rabeprazole sodium 20 mg enteric tablet, 30 |
| 8508T | Pariet, JC – RABEPRAZOLE, rabeprazole sodium 20 mg enteric tablet, 30 |
| 8509W | Pariet, JC – RABEPRAZOLE, rabeprazole sodium 20 mg enteric tablet, 30 |
| 11869Q | NOUMED RISPERIDONE, VO – RISPERIDONE, risperidone 500 microgram tablet, 60 |
| 11881H | NOUMED RISPERIDONE, VO – RISPERIDONE, risperidone 500 microgram tablet, 60 |
| 8787L | NOUMED RISPERIDONE, VO – RISPERIDONE, risperidone 500 microgram tablet, 60 |
| 8869T | NOUMED RISPERIDONE, VO – RISPERIDONE, risperidone 500 microgram tablet, 60 |
| 10551H | Rizatriptan ODT APOTEX, GX – RIZATRIPTAN, rizatriptan 10 mg orally disintegrating tablet, 2 |
| 14006E | Tobramycin WKT, JU – TOBRAMYCIN, tobramycin 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules |
| 5442K | Tobramycin WKT, JU – TOBRAMYCIN, tobramycin 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules |
Deletion – Equivalence Indicator
| 9318K | PHARMACOR DABIGATRAN, CR – DABIGATRAN, dabigatran etexilate 75 mg capsule, 10 |
| 9322P | PHARMACOR DABIGATRAN, CR – DABIGATRAN, dabigatran etexilate 75 mg capsule, 10 |
Deletion – Note
| 14665W | BELZUTIFAN, belzutifan 40 mg tablet, 90 (Welireg) |
| 14589W | BIMEKIZUMAB, bimekizumab 160 mg/mL injection, 2 x 1 mL pen devices (Bimzelx) |
| 14590X | BIMEKIZUMAB, bimekizumab 160 mg/mL injection, 2 x 1 mL pen devices (Bimzelx) |
| 13277T | CANNABIDIOL, cannabidiol 100 mg/mL oral liquid, 100 mL (Epidyolex) |
| 14601L | ETRASIMOD, etrasimod 2 mg tablet, 28 (Velsipity) |
| 10104T | FERRIC CARBOXYMALTOSE, iron (as ferric carboxymaltose) 500 mg/10 mL injection, 10 mL vial (Ferinject) |
| 11702X | FERRIC CARBOXYMALTOSE, iron (as ferric carboxymaltose) 1 g/20 mL injection, 20 mL vial (Ferinject) |
| 11884L | LISDEXAMFETAMINE, lisdexamfetamine dimesilate 20 mg capsule, 30 (Vyvanse) |
| 10486X | LISDEXAMFETAMINE, lisdexamfetamine dimesilate 30 mg capsule, 30 (Vyvanse) |
| 11898F | LISDEXAMFETAMINE, lisdexamfetamine dimesilate 40 mg capsule, 30 (Vyvanse) |
| 10474G | LISDEXAMFETAMINE, lisdexamfetamine dimesilate 50 mg capsule, 30 (Vyvanse) |
| 11897E | LISDEXAMFETAMINE, lisdexamfetamine dimesilate 60 mg capsule, 30 (Vyvanse) |
| 10492F | LISDEXAMFETAMINE, lisdexamfetamine dimesilate 70 mg capsule, 30 (Vyvanse) |
| 10042M | PAZOPANIB, pazopanib 200 mg tablet, 90 (Pazopanib ADVZ, Votrient) |
| 10047T | PAZOPANIB, pazopanib 200 mg tablet, 90 (Pazopanib ADVZ, Votrient) |
| 10054E | PAZOPANIB, pazopanib 200 mg tablet, 30 (Pazopanib ADVZ, Votrient) |
| 11252F | PAZOPANIB, pazopanib 200 mg tablet, 90 (Pazopanib ADVZ, Votrient) |
| 2029T | PAZOPANIB, pazopanib 200 mg tablet, 90 (Pazopanib ADVZ, Votrient) |
| 2232L | PAZOPANIB, pazopanib 200 mg tablet, 30 (Pazopanib ADVZ, Votrient) |
| 10041L | PAZOPANIB, pazopanib 400 mg tablet, 60 (Pazopanib ADVZ, Votrient) |
| 10043N | PAZOPANIB, pazopanib 400 mg tablet, 60 (Pazopanib ADVZ, Votrient) |
| 10052C | PAZOPANIB, pazopanib 400 mg tablet, 30 (Pazopanib ADVZ, Votrient) |
| 11261Q | PAZOPANIB, pazopanib 400 mg tablet, 60 (Pazopanib ADVZ, Votrient) |
| 2030W | PAZOPANIB, pazopanib 400 mg tablet, 60 (Pazopanib ADVZ, Votrient) |
| 2201W | PAZOPANIB, pazopanib 400 mg tablet, 30 (Pazopanib ADVZ, Votrient) |
| 14641N | ROMOSOZUMAB, romosozumab 105 mg/1.17 mL injection, 2 x 1.17 mL syringes (Evenity) |
Deletion – Restriction
| 14665W | BELZUTIFAN, belzutifan 40 mg tablet, 90 (Welireg) |
| 14589W | BIMEKIZUMAB, bimekizumab 160 mg/mL injection, 2 x 1 mL pen devices (Bimzelx) |
| 14590X | BIMEKIZUMAB, bimekizumab 160 mg/mL injection, 2 x 1 mL pen devices (Bimzelx) |
| 14602M | BIMEKIZUMAB, bimekizumab 160 mg/mL injection, 2 x 1 mL pen devices (Bimzelx) |
| 14601L | ETRASIMOD, etrasimod 2 mg tablet, 28 (Velsipity) |
| 14641N | ROMOSOZUMAB, romosozumab 105 mg/1.17 mL injection, 2 x 1.17 mL syringes (Evenity) |
Alterations
Alteration – Authorised Prescriber
| From | To | ||
| 11723B | BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin tetrahydrate 600 000 units (517 mg)/1.17 mL injection, 10 x 1.17 mL syringes (Bicillin L-A) | M,N | M,N,W |
| 2267H | BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin tetrahydrate 1.2 million units (1016.6 mg)/2.3 mL injection, 10 x 2.3 mL syringes (Bicillin L-A) | M,N | M,N,W |
| 15058M | BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin 1.2 million units powder for injection [1 vial] (&) inert substance diluent [4 mL ampoule], 1 pack (Lentocilin S 1200 (Portugal)) | M,N | M,N,W |
| 13816E | BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin 1.2 million units powder for injection [1 vial] (&) inert substance diluent [5 mL vial], 1 pack (Extencilline Benzathine Benzylpenicillin (France)) | M,N | M,N,W |
Alteration – Note
| 12361N | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (Hadlima, Humira, Hyrimoz, Yuflyma) |
| 12363Q | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Humira, Hyrimoz, Yuflyma) |
| 12376J | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Humira, Hyrimoz, Yuflyma) |
| 12383R | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Humira, Hyrimoz, Yuflyma) |
| 12414J | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Humira, Hyrimoz, Yuflyma) |
| 12442W | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (Hadlima, Humira, Hyrimoz, Yuflyma) |
| 12454L | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Humira, Hyrimoz, Yuflyma) |
| 13208E | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (Hadlima, Hyrimoz, Yuflyma) |
| 13221W | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Hyrimoz, Yuflyma) |
| 13226D | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Hyrimoz, Yuflyma) |
| 13763J | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (Hadlima, Hyrimoz, Yuflyma) |
| 13764K | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Hyrimoz, Yuflyma) |
| 12327T | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (, Amgevita, Hadlima, Hyrimoz) |
| 12328W | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz) |
| 12330Y | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz) |
| 12356H | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz) |
| 12369B | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz) |
| 12385W | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz) |
| 13744J | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (, Amgevita, Hadlima, Hyrimoz) |
| 13754X | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz) |
| 9077R | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (, Amgevita, Hadlima, Hyrimoz) |
| 9078T | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (, Amgevita, Hadlima, Hyrimoz) |
| 9103D | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz) |
| 9104E | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz) |
| 12395J | ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL syringe (Humira, Yuflyma) |
| 12408C | ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL syringe (Humira, Yuflyma) |
| 12448E | ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device (Humira, Hyrimoz, Yuflyma) |
| 12449F | ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device (Humira, Hyrimoz, Yuflyma) |
| 12450G | ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device (Humira, Hyrimoz, Yuflyma) |
| 12524E | ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL syringe (Humira, Yuflyma) |
| 14587R | ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device (Hyrimoz, Yuflyma) |
| 14622N | ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL syringe (Yuflyma) |
| 14602M | BIMEKIZUMAB, bimekizumab 160 mg/mL injection, 2 x 1 mL pen devices (Bimzelx) |
| 14618J | BIMEKIZUMAB, bimekizumab 160 mg/mL injection, 2 x 1 mL pen devices (Bimzelx) |
| 10137M | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia) |
| 10897M | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia) |
| 10904X | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia) |
| 11318Q | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL pen devices (Cimzia) |
| 11319R | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL pen devices (Cimzia) |
| 11320T | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL pen devices (Cimzia) |
| 15071F | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |
| 15082T | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |
| 15088D | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |
| 8778B | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 8779C | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 11215G | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Erelzi, Nepexto) |
| 13774Y | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Erelzi, Nepexto) |
| 9455P | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Erelzi, Nepexto) |
| 9456Q | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Erelzi, Nepexto) |
| 11217J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Erelzi) |
| 13751R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Erelzi) |
| 9085E | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel, Erelzi) |
| 9086F | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel, Erelzi) |
| 11361Y | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL pen device (Simponi) |
| 11376R | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL pen device (Simponi) |
| 3434R | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi) |
| 3436W | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi) |
| 13048R | INFLIXIMAB, infliximab 120 mg/mL injection, 1 mL pen device (Remsima SC) |
| 13049T | INFLIXIMAB, infliximab 120 mg/mL injection, 1 mL pen device (Remsima SC) |
| 13057F | INFLIXIMAB, infliximab 120 mg/mL injection, 1 mL syringe (Remsima SC) |
| 13069W | INFLIXIMAB, infliximab 120 mg/mL injection, 1 mL syringe (Remsima SC) |
| 15064W | IPTACOPAN, Iptacopan 200 mg capsule, 56 (Fabhalta) |
| 12209N | IXEKIZUMAB, ixekizumab 80 mg/mL injection, 2 x 1 mL pen devices (Taltz) |
| 12217B | IXEKIZUMAB, ixekizumab 80 mg/mL injection, 2 x 1 mL pen devices (Taltz) |
| 10890E | SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL pen device (Cosentyx) |
| 10893H | SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL pen device (Cosentyx) |
| 10906B | SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL pen device (Cosentyx) |
| 14146M | SECUKINUMAB, secukinumab 150 mg/mL injection, 2 x 1 mL pen devices (Cosentyx) |
| 14154Y | SECUKINUMAB, secukinumab 150 mg/mL injection, 2 x 1 mL pen devices (Cosentyx) |
| 14161H | SECUKINUMAB, secukinumab 150 mg/mL injection, 2 x 1 mL pen devices (Cosentyx) |
| 14956E | SECUKINUMAB, Secukinumab 300 mg/2 mL injection, 2 mL pen device (Cosentyx) |
| 14957F | SECUKINUMAB, Secukinumab 300 mg/2 mL injection, 2 mL pen device (Cosentyx) |
| 14970X | SECUKINUMAB, Secukinumab 300 mg/2 mL injection, 2 mL pen device (Cosentyx) |
| 15004Q | SECUKINUMAB, Secukinumab 300 mg/2 mL injection, 2 mL pen device (Cosentyx) |
| 15029B | SECUKINUMAB, Secukinumab 300 mg/2 mL injection, 2 mL pen device (Cosentyx) |
| 15030C | SECUKINUMAB, Secukinumab 300 mg/2 mL injection, 2 mL pen device (Cosentyx) |
| 13345J | TOFACITINIB, tofacitinib 5 mg tablet, 56 (Xeljanz) |
| 13349N | TOFACITINIB, tofacitinib 5 mg tablet, 56 (Xeljanz) |
| 12621G | UPADACITINIB, upadacitinib 15 mg modified release tablet, 28 (Rinvoq) |
| 12625L | UPADACITINIB, upadacitinib 15 mg modified release tablet, 28 (Rinvoq) |
Alteration – Restriction
| 12414J | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Humira, Hyrimoz, Yuflyma) |
| 12454L | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Humira, Hyrimoz, Yuflyma) |
| 12356H | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz) |
| 12369B | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz) |
| 12408C | ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL syringe (Humira, Yuflyma) |
| 12448E | ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device (Humira, Hyrimoz, Yuflyma) |
| 12450G | ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device (Humira, Hyrimoz, Yuflyma) |
| 12524E | ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL syringe (Humira, Yuflyma) |
| 13277T | CANNABIDIOL, cannabidiol 100 mg/mL oral liquid, 100 mL (Epidyolex) |
| 15071F | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |
| 15088D | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |
| 11362B | EVEROLIMUS, everolimus 5 mg tablet, 30 (Afinitor) |
| 11377T | EVEROLIMUS, everolimus 10 mg tablet, 30 (Afinitor) |
| 15064W | IPTACOPAN, Iptacopan 200 mg capsule, 56 (Fabhalta) |
| 14146M | SECUKINUMAB, secukinumab 150 mg/mL injection, 2 x 1 mL pen devices (Cosentyx) |
| 14154Y | SECUKINUMAB, secukinumab 150 mg/mL injection, 2 x 1 mL pen devices (Cosentyx) |
| 14161H | SECUKINUMAB, secukinumab 150 mg/mL injection, 2 x 1 mL pen devices (Cosentyx) |
| 14970X | SECUKINUMAB, Secukinumab 300 mg/2 mL injection, 2 mL pen device (Cosentyx) |
| 15004Q | SECUKINUMAB, Secukinumab 300 mg/2 mL injection, 2 mL pen device (Cosentyx) |
| 15030C | SECUKINUMAB, Secukinumab 300 mg/2 mL injection, 2 mL pen device (Cosentyx) |
| 10004M | SUNITINIB, sunitinib 12.5 mg capsule, 28 (Sunitinib Sandoz, Sutent) |
| 2959R | SUNITINIB, sunitinib 25 mg capsule, 28 (ARX-Sunitinib, Sunitinib Sandoz, Sutent) |
| 10464R | SUNITINIB, sunitinib 37.5 mg capsule, 28 (ARX-Sunitinib, Sunitinib Sandoz, Sutent) |
| 2837H | SUNITINIB, sunitinib 50 mg capsule, 28 (ARX-Sunitinib, Sunitinib Sandoz, Sutent) |
Alteration – Manufacturer Code
| From | To | ||
| 1211R | Clomid – CLOMIFENE, clomifene citrate 50 mg tablet, 10 | SW | VJ |
| 14711G | Yasmin – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 28 | BN | XW |
| 14725B | Yasmin – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 3 x 28 | BN | XW |
| 14709E | Yaz – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 3 x 28 | BN | XW |
| 14710F | Yaz – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 28 | BN | XW |
| 11202N | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices | RF | OQ |
| 11215G | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices | RF | OQ |
| 11218K | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices | RF | OQ |
| 11221N | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices | RF | OQ |
| 11222P | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices | RF | OQ |
| 13687J | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices | RF | OQ |
| 13708L | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices | RF | OQ |
| 13774Y | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices | RF | OQ |
| 9455P | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices | RF | OQ |
| 9456Q | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices | RF | OQ |
| 9457R | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices | RF | OQ |
| 9458T | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices | RF | OQ |
| 9459W | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices | RF | OQ |
| 9460X | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices | RF | OQ |
| 9461Y | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices | RF | OQ |
| 9462B | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices | RF | OQ |
| 11198J | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices | RF | OQ |
| 11201M | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices | RF | OQ |
| 11211C | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes | RF | OQ |
| 11216H | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes | RF | OQ |
| 11217J | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes | RF | OQ |
| 11224R | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes | RF | OQ |
| 11225T | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes | RF | OQ |
| 13698Y | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes | RF | OQ |
| 13707K | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes | RF | OQ |
| 13751R | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes | RF | OQ |
| 9085E | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes | RF | OQ |
| 9086F | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes | RF | OQ |
| 9087G | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes | RF | OQ |
| 9088H | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes | RF | OQ |
| 9089J | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes | RF | OQ |
| 9090K | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes | RF | OQ |
| 9091L | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes | RF | OQ |
| 9431J | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes | RF | OQ |
| 11196G | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes | RF | OQ |
| 11208X | Brenzys – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes | RF | OQ |
| 2913H | Microlut 28 – LEVONORGESTREL, levonorgestrel 30 microgram tablet, 112 tablets [4 x 28] | BN | XW |
| 1456P | Microgynon 50 ED – LEVONORGESTREL + ETHINYLESTRADIOL, levonorgestrel 125 microgram + ethinylestradiol 50 microgram tablet [21] (&) inert substance tablet [7], 4 x 28 | BN | XW |
| 1394J | Levlen ED – LEVONORGESTREL + ETHINYLESTRADIOL, levonorgestrel 150 microgram + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 4 x 28 | SY | XW |
| 12623J | Ocaliva – OBETICHOLIC ACID, obeticholic acid 5 mg tablet, 30 | EU | GH |
| 12630R | Ocaliva – OBETICHOLIC ACID, obeticholic acid 5 mg tablet, 30 | EU | GH |
| 12640G | Ocaliva – OBETICHOLIC ACID, obeticholic acid 10 mg tablet, 30 | EU | GH |
Alteration – Number of Repeats
| From | To | ||
| 15071F | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) | 7 | 15 |
Supply Only
Supply Only Commencing
| 14223N | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 14252D | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 14253E | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 14273F | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 14274G | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 14294H | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 14295J | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 14750H | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 14751J | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 14764C | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 14777R | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 14974D | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 14984P | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 15040N | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 1062X | BETHANECHOL, bethanechol chloride 10 mg tablet, 100 (Uro-Carb) |
| 14613D | IBRUTINIB, ibrutinib 140 mg capsule, 90 (Imbruvica) |
| 14579H | IBRUTINIB, ibrutinib 280 mg tablet, 30 (Imbruvica) |
| 14619K | IBRUTINIB, ibrutinib 420 mg tablet, 30 (Imbruvica) |
| 8461H | PAMIDRONATE DISODIUM, pamidronate disodium 15 mg/5 mL injection, 5 mL vial (Pamisol) |
| 8462J | PAMIDRONATE DISODIUM, pamidronate disodium 30 mg/10 mL injection, 10 mL vial (Pamisol) |
| 1948M | PROMETHAZINE, promethazine hydrochloride 50 mg/2 mL injection, 5 x 2 mL ampoules (DBL Promethazine Hydrochloride) |
| 3374N | PROMETHAZINE, promethazine hydrochloride 50 mg/2 mL injection, 5 x 2 mL ampoules (DBL Promethazine Hydrochloride) |
| 9479X | SILVER SULFADIAZINE, silver sulfadiazine 1% cream, 50 g (Flamazine) |
| 14426G | SOY LECITHIN + TOCOPHEROL + VITAMIN A, soy lecithin 1% + tocopherol 0.002% + vitamin A palmitate 0.025% spray, 100 actuations (tearsagain) |
| 5545W | SOY LECITHIN + TOCOPHEROL + VITAMIN A, soy lecithin 1% + tocopherol 0.002% + vitamin A palmitate 0.025% spray, 100 actuations (tearsagain) |
| 9448G | SOY LECITHIN + TOCOPHEROL + VITAMIN A, soy lecithin 1% + tocopherol 0.002% + vitamin A palmitate 0.025% spray, 100 actuations (tearsagain) |
| 13859K | TOREMIFENE, toremifene 60 mg tablet, 30 (Fareston) |
| 8216K | TOREMIFENE, toremifene 60 mg tablet, 30 (Fareston) |
| 14599J | VENETOCLAX, venetoclax 10 mg tablet [14] (&) venetoclax 50 mg tablet [7] (&) venetoclax 100 mg tablet [7] (&) venetoclax 100 mg tablet [14], 1 pack (Venclexta) |
| 14581K | VENETOCLAX, venetoclax 100 mg tablet, 120 (Venclexta) |
Advance Notices
1 January 2026
Deletion – Brand
| 11941L | AlphaClav Duo, AF – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 500 mg + clavulanic acid 125 mg tablet, 10 |
| 1891M | AlphaClav Duo, AF – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 500 mg + clavulanic acid 125 mg tablet, 10 |
| 5008N | AlphaClav Duo, AF – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 500 mg + clavulanic acid 125 mg tablet, 10 |
| 13790T | Extencilline Benzathine Benzylpenicillin (France), YO – BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin 1.2 million units powder for injection [1 vial] (&) inert substance diluent [5 mL vial], 1 pack |
| 13816E | Extencilline Benzathine Benzylpenicillin (France), YO – BENZATHINE BENZYLPENICILLIN, benzathine benzylpenicillin 1.2 million units powder for injection [1 vial] (&) inert substance diluent [5 mL vial], 1 pack |
| 14496Y | Alphagan P 1.5, VE – BRIMONIDINE, brimonidine tartrate 0.15% eye drops, 5 mL |
| 5298W | Alphagan P 1.5, VE – BRIMONIDINE, brimonidine tartrate 0.15% eye drops, 5 mL |
| 5563T | Alphagan P 1.5, VE – BRIMONIDINE, brimonidine tartrate 0.15% eye drops, 5 mL |
| 3162K | NOUMED DIAZEPAM, VO – DIAZEPAM, diazepam 5 mg tablet, 50 |
| 5072Y | NOUMED DIAZEPAM, VO – DIAZEPAM, diazepam 5 mg tablet, 50 |
| 14259L | Permethrin Cream 5% w/w (Encube Ethicals, USA), RQ – PERMETHRIN, permethrin 5% cream, 60 g |
1 February 2026
Deletion – Brand
| 13562T | Amlodipine APOTEX, GX – AMLODIPINE, amlodipine 10 mg tablet, 30 |
| 2752W | Amlodipine APOTEX, GX – AMLODIPINE, amlodipine 10 mg tablet, 30 |
| 13535J | EzSimva GH 10/40, GQ – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 40 mg tablet, 30 |
| 8881K | EzSimva GH 10/40, GQ – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 40 mg tablet, 30 |
| 13558N | Lescol XL, NV – FLUVASTATIN, fluvastatin 80 mg modified release tablet, 28 |
| 2863Q | Lescol XL, NV – FLUVASTATIN, fluvastatin 80 mg modified release tablet, 28 |
| 11872W | Risperdal, JC – RISPERIDONE, risperidone 500 microgram tablet, 20 |
| 11873X | Risperdal, JC – RISPERIDONE, risperidone 500 microgram tablet, 20 |
| 11877D | Risperdal, JC – RISPERIDONE, risperidone 1 mg tablet, 60 |
| 11879F | Risperdal, JC – RISPERIDONE, risperidone 1 mg tablet, 60 |
| 1842Y | Risperdal, JC – RISPERIDONE, risperidone 500 microgram tablet, 20 |
| 1846E | Risperdal, JC – RISPERIDONE, risperidone 500 microgram tablet, 20 |
| 3169T | Risperdal, JC – RISPERIDONE, risperidone 1 mg tablet, 60 |
| 3170W | Risperdal, JC – RISPERIDONE, risperidone 2 mg tablet, 60 |
| 3171X | Risperdal, JC – RISPERIDONE, risperidone 3 mg tablet, 60 |
| 3172Y | Risperdal, JC – RISPERIDONE, risperidone 4 mg tablet, 60 |
| 8789N | Risperdal, JC – RISPERIDONE, risperidone 1 mg tablet, 60 |
| 9079W | Risperdal, JC – RISPERIDONE, risperidone 2 mg tablet, 60 |
| 11286B | Qtern 5/10, AP – SAXAGLIPTIN + DAPAGLIFLOZIN, saxagliptin 5 mg + dapagliflozin 10 mg tablet, 28 |
| 13855F | Qtern 5/10, AP – SAXAGLIPTIN + DAPAGLIFLOZIN, saxagliptin 5 mg + dapagliflozin 10 mg tablet, 28 |
| 13450X | Pritor/Amlodipine, FI – TELMISARTAN + AMLODIPINE, telmisartan 80 mg + amlodipine 5 mg tablet, 28 |
| 13450X | Twynsta, BY – TELMISARTAN + AMLODIPINE, telmisartan 80 mg + amlodipine 5 mg tablet, 28 |
| 13451Y | Pritor/Amlodipine, FI – TELMISARTAN + AMLODIPINE, telmisartan 80 mg + amlodipine 10 mg tablet, 28 |
| 13451Y | Twynsta, BY – TELMISARTAN + AMLODIPINE, telmisartan 80 mg + amlodipine 10 mg tablet, 28 |
| 13483P | Pritor/Amlodipine, FI – TELMISARTAN + AMLODIPINE, telmisartan 40 mg + amlodipine 5 mg tablet, 28 |
| 13483P | Twynsta, BY – TELMISARTAN + AMLODIPINE, telmisartan 40 mg + amlodipine 5 mg tablet, 28 |
| 13515H | Pritor/Amlodipine, FI – TELMISARTAN + AMLODIPINE, telmisartan 40 mg + amlodipine 10 mg tablet, 28 |
| 13515H | Twynsta, BY – TELMISARTAN + AMLODIPINE, telmisartan 40 mg + amlodipine 10 mg tablet, 28 |
| 8978M | Pritor/Amlodipine, FI – TELMISARTAN + AMLODIPINE, telmisartan 40 mg + amlodipine 5 mg tablet, 28 |
| 8978M | Twynsta, BY – TELMISARTAN + AMLODIPINE, telmisartan 40 mg + amlodipine 5 mg tablet, 28 |
| 8979N | Pritor/Amlodipine, FI – TELMISARTAN + AMLODIPINE, telmisartan 40 mg + amlodipine 10 mg tablet, 28 |
| 8979N | Twynsta, BY – TELMISARTAN + AMLODIPINE, telmisartan 40 mg + amlodipine 10 mg tablet, 28 |
| 8980P | Pritor/Amlodipine, FI – TELMISARTAN + AMLODIPINE, telmisartan 80 mg + amlodipine 5 mg tablet, 28 |
| 8980P | Twynsta, BY – TELMISARTAN + AMLODIPINE, telmisartan 80 mg + amlodipine 5 mg tablet, 28 |
| 8981Q | Pritor/Amlodipine, FI – TELMISARTAN + AMLODIPINE, telmisartan 80 mg + amlodipine 10 mg tablet, 28 |
| 8981Q | Twynsta, BY – TELMISARTAN + AMLODIPINE, telmisartan 80 mg + amlodipine 10 mg tablet, 28 |
| 2285G | Lamisil (Novartis Pharmaceuticals Australia Pty Limited), NV – TERBINAFINE, terbinafine 250 mg tablet, 42 |
| 2804N | Lamisil (Novartis Pharmaceuticals Australia Pty Limited), NV – TERBINAFINE, terbinafine 250 mg tablet, 42 |
1 March 2026
Deletion – Brand
| 10019H | Erlotinib APOTEX, TX – ERLOTINIB, erlotinib 100 mg tablet, 30 |
| 10020J | Erlotinib APOTEX, TX – ERLOTINIB, erlotinib 100 mg tablet, 30 |
| 11260P | Erlotinib APOTEX, TX – ERLOTINIB, erlotinib 100 mg tablet, 30 |
| 10791Y | Momasone, AS – MOMETASONE, mometasone furoate 0.1% ointment, 15 g |
| 10793C | Momasone, AS – MOMETASONE, mometasone furoate 0.1% ointment, 15 g |
| 10812C | Momasone, AS – MOMETASONE, mometasone furoate 0.1% ointment, 15 g |
| 10814E | Momasone, AS – MOMETASONE, mometasone furoate 0.1% ointment, 15 g |
| 10828X | Momasone, AS – MOMETASONE, mometasone furoate 0.1% ointment, 15 g |
| 1915T | Momasone, AS – MOMETASONE, mometasone furoate 0.1% ointment, 15 g |
Palliative Care
Additions
Addition – Brand
| 12519X | HALOPERIDOL MEDSURGE, DZ – HALOPERIDOL, haloperidol 5 mg/mL injection, 10 x 1 mL ampoules |
Addition – Equivalence Indicator
| 12519X | Serenace, AS – HALOPERIDOL, haloperidol 5 mg/mL injection, 10 x 1 mL ampoules |
Deletions
Deletion – Brand
| 5389P | Molaxole, XT – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets |
Advance Notices
1 January 2026
Deletion – Brand
| 5356X | NOUMED DIAZEPAM, VO – DIAZEPAM, diazepam 5 mg tablet, 50 |
Highly Specialised Drugs Program (Private Hospital)
Additions
Addition – Item
| 15132K | APOMORPHINE, Apomorphine hydrochloride hemihydrate 100 mg/20 mL injection, 5 x 20 mL cartridges (MOVAPO POD) |
| 15113K | OCRELIZUMAB, ocrelizumab 920 mg/23 mL injection, 23 mL vial (Ocrevus SC) |
| 15117P | PEGCETACOPLAN, pegcetacoplan 1.08 g/20 mL injection, 20 mL vial (Empaveli) |
Deletions
Deletion – Brand
| 12384T | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 9679K | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
Deletion – Note
| 14679N | VEDOLIZUMAB, vedolizumab 300 mg injection, 1 vial (Entyvio) |
Deletion – Restriction
| 14679N | VEDOLIZUMAB, vedolizumab 300 mg injection, 1 vial (Entyvio) |
Alterations
Alteration – Note
| 12864C | ECULIZUMAB, eculizumab 300 mg/30 mL injection, 30 mL vial (Soliris) |
| 12896R | ECULIZUMAB, eculizumab 300 mg/30 mL injection, 30 mL vial (Soliris) |
| 12899X | ECULIZUMAB, eculizumab 300 mg/30 mL injection, 30 mL vial (Soliris) |
| 11488P | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remsima, Renflexis) |
| 11489Q | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remicade, Remsima, Renflexis) |
| 13778E | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remsima, Renflexis) |
| 6448J | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remicade, Remsima, Renflexis) |
| 13191G | PEGCETACOPLAN, pegcetacoplan 1.08 g/20 mL injection, 20 mL vial (Empaveli) |
| 13196M | PEGCETACOPLAN, pegcetacoplan 1.08 g/20 mL injection, 20 mL vial (Empaveli) |
| 13197N | PEGCETACOPLAN, pegcetacoplan 1.08 g/20 mL injection, 20 mL vial (Empaveli) |
| 12841W | RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris) |
| 12895Q | RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris) |
| 12897T | RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris) |
| 12901B | RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris) |
Alteration – Restriction
| 12864C | ECULIZUMAB, eculizumab 300 mg/30 mL injection, 30 mL vial (Soliris) |
| 12896R | ECULIZUMAB, eculizumab 300 mg/30 mL injection, 30 mL vial (Soliris) |
| 12899X | ECULIZUMAB, eculizumab 300 mg/30 mL injection, 30 mL vial (Soliris) |
| 11527Q | LANREOTIDE, lanreotide 120 mg/0.5 mL injection, 0.5 mL syringe (Mytolac, Somatuline Autogel) |
| 11894B | OCTREOTIDE, octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack (Octreotide Depot, Sandostatin LAR) |
| 13191G | PEGCETACOPLAN, pegcetacoplan 1.08 g/20 mL injection, 20 mL vial (Empaveli) |
| 13196M | PEGCETACOPLAN, pegcetacoplan 1.08 g/20 mL injection, 20 mL vial (Empaveli) |
| 13197N | PEGCETACOPLAN, pegcetacoplan 1.08 g/20 mL injection, 20 mL vial (Empaveli) |
| 12841W | RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris) |
| 12895Q | RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris) |
| 12897T | RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris) |
| 12901B | RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris) |
Supply Only
Supply Only - Period Commencing
| 14276J | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 14285W | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 6286W | PAMIDRONATE DISODIUM, pamidronate disodium 15 mg/5 mL injection, 5 mL vial (Pamisol) |
| 6287X | PAMIDRONATE DISODIUM, pamidronate disodium 30 mg/10 mL injection, 10 mL vial (Pamisol) |
Supply Only - Period Ending
| 14170T | DAUNORUBICIN + CYTARABINE, daunorubicin hydrochloride 44 mg + cytarabine 100 mg injection, 1 vial (Vyxeos) |
| 14214D | DAUNORUBICIN + CYTARABINE, daunorubicin hydrochloride 44 mg + cytarabine 100 mg injection, 1 vial (Vyxeos) |
| 13826Q | NIVOLUMAB + RELATLIMAB, nivolumab 240 mg/20 mL + relatlimab 80 mg/20 mL injection, 20 mL vial (Opdualag) |
| 13829W | NIVOLUMAB + RELATLIMAB, nivolumab 240 mg/20 mL + relatlimab 80 mg/20 mL injection, 20 mL vial (Opdualag) |
Advance Notices
1 January 2026
Deletion – Brand
| 11036W | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 11042E | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 11055W | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 11063G | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 12011E | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 12020P | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 12037M | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 12038N | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 12050F | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 12060R | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 12068E | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 12071H | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 12980E | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 12984J | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 12986L | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 12993W | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 13642B | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 13657T | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 13658W | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 13660Y | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 15073H | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 15079P | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 15096M | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 15103X | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 2796E | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 2798G | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 9642L | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 9643M | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 9644N | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 9645P | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 10084R | Mozobil, GZ – PLERIXAFOR, plerixafor 24 mg/1.2 mL injection, 1.2 mL vial |
Highly Specialised Drugs Program (Public Hospital)
Additions
Addition – Item
| 15111H | APOMORPHINE, Apomorphine hydrochloride hemihydrate 100 mg/20 mL injection, 5 x 20 mL cartridges (MOVAPO POD) |
| 15120T | OCRELIZUMAB, ocrelizumab 920 mg/23 mL injection, 23 mL vial (Ocrevus SC) |
| 15127E | PEGCETACOPLAN, pegcetacoplan 1.08 g/20 mL injection, 20 mL vial (Empaveli) |
Deletions
Deletion – Brand
| 12348X | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
| 9662M | Abrilada, PF – ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes |
Deletion – Note
| 14670D | VEDOLIZUMAB, vedolizumab 300 mg injection, 1 vial (Entyvio) |
Deletion – Restriction
| 14670D | VEDOLIZUMAB, vedolizumab 300 mg injection, 1 vial (Entyvio) |
Alterations
Alteration – Note
| 12840T | ECULIZUMAB, eculizumab 300 mg/30 mL injection, 30 mL vial (Soliris) |
| 12877R | ECULIZUMAB, eculizumab 300 mg/30 mL injection, 30 mL vial (Soliris) |
| 12900Y | ECULIZUMAB, eculizumab 300 mg/30 mL injection, 30 mL vial (Soliris) |
| 11482H | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remicade, Remsima, Renflexis) |
| 11486M | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remsima, Renflexis) |
| 13765L | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remsima, Renflexis) |
| 5753T | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remicade, Remsima, Renflexis) |
| 13175K | PEGCETACOPLAN, pegcetacoplan 1.08 g/20 mL injection, 20 mL vial (Empaveli) |
| 13180Q | PEGCETACOPLAN, pegcetacoplan 1.08 g/20 mL injection, 20 mL vial (Empaveli) |
| 13185Y | PEGCETACOPLAN, pegcetacoplan 1.08 g/20 mL injection, 20 mL vial (Empaveli) |
| 12884D | RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris) |
| 12898W | RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris) |
| 12856P | RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris) |
| 12883C | RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris) |
Alteration – Restriction
| 12840T | ECULIZUMAB, eculizumab 300 mg/30 mL injection, 30 mL vial (Soliris) |
| 12877R | ECULIZUMAB, eculizumab 300 mg/30 mL injection, 30 mL vial (Soliris) |
| 12900Y | ECULIZUMAB, eculizumab 300 mg/30 mL injection, 30 mL vial (Soliris) |
| 11513Y | LANREOTIDE, lanreotide 120 mg/0.5 mL injection, 0.5 mL syringe (Mytolac, Somatuline Autogel) |
| 11893Y | OCTREOTIDE, octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack (Octreotide Depot, Sandostatin LAR) |
| 13175K | PEGCETACOPLAN, pegcetacoplan 1.08 g/20 mL injection, 20 mL vial (Empaveli) |
| 13180Q | PEGCETACOPLAN, pegcetacoplan 1.08 g/20 mL injection, 20 mL vial (Empaveli) |
| 13185Y | PEGCETACOPLAN, pegcetacoplan 1.08 g/20 mL injection, 20 mL vial (Empaveli) |
| 12884D | RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris) |
| 12898W | RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris) |
| 12856P | RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris) |
| 12883C | RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris) |
Supply Only
Supply Only - Period Commencing
| 14235F | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 14286X | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 5667G | PAMIDRONATE DISODIUM, pamidronate disodium 15 mg/5 mL injection, 5 mL vial (Pamisol) |
| 5668H | PAMIDRONATE DISODIUM, pamidronate disodium 30 mg/10 mL injection, 10 mL vial (Pamisol) |
Supply Only - Period Ending
| 14171W | DAUNORUBICIN + CYTARABINE, daunorubicin hydrochloride 44 mg + cytarabine 100 mg injection, 1 vial (Vyxeos) |
| 14205P | DAUNORUBICIN + CYTARABINE, daunorubicin hydrochloride 44 mg + cytarabine 100 mg injection, 1 vial (Vyxeos) |
| 13817F | NIVOLUMAB + RELATLIMAB, nivolumab 240 mg/20 mL + relatlimab 80 mg/20 mL injection, 20 mL vial (Opdualag) |
| 13830X | NIVOLUMAB + RELATLIMAB, nivolumab 240 mg/20 mL + relatlimab 80 mg/20 mL injection, 20 mL vial (Opdualag |
Advance Notices
1 January 2026
Deletion – Brand
| 11029L | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 11041D | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 11062F | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 11064H | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 12026Y | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 12034J | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 12036L | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 12039P | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 12057N | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 12059Q | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 12061T | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 12062W | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 12979D | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 12985K | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 12988N | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 12991R | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 13630J | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 13636Q | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 13641Y | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 13661B | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 15067B | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 15078N | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 15104Y | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 15106C | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 2799H | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 2802L | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 5783J | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 5784K | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 5785L | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 5786M | Lenalidomide Viatris, AF – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 10083Q | Mozobil, GZ – PLERIXAFOR, plerixafor 24 mg/1.2 mL injection, 1.2 mL vial |
Highly Specialised Drugs Program (Community Access)
Alterations
Alteration – Restriction
| 11736Q | LANREOTIDE, lanreotide 120 mg/0.5 mL injection, 0.5 mL syringe (Mytolac, Somatuline Autogel) |
| 11896D | OCTREOTIDE, octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack (Octreotide Depot, Sandostatin LAR) |
Advance Notices
1 January 2026
Deletion – Brand
| 10321F | Reyataz, BQ – ATAZANAVIR, atazanavir 300 mg capsule, 30 |
| 10349Q | Reyataz, BQ – ATAZANAVIR, atazanavir 200 mg capsule, 60 |
IVF Program
Advance Notices
1 January 2026
Deletion – Brand
| 12851J | Choriomon 5000 I.E, DZ – HUMAN CHORIONIC GONADOTROPHIN, human chorionic gonadotrophin 5000 units injection [3 vials] (&) inert substance diluent [3 x 1 mL syringes], 1 pack |
Repatriation Pharmaceutical Benefits
Advance Notices
1 February 2026
Deletion – Brand
| 4011D | Lamisil (Novartis Pharmaceuticals Australia Pty Limited), NV – TERBINAFINE, terbinafine 250 mg tablet, 42 |
Efficient Funding of Chemotherapy (Private Hospital)
Additions
Addition – Item
| 15126D |
TORIPALIMAB, Toripalimab 240 mg/6 mL injection, 6 mL vial (Zytorvi) |
Addition – Brand
| 10140Q | Eribulin Dr.Reddy's, RZ – ERIBULIN, eribulin mesilate 1 mg/2 mL injection, 2 mL vial |
| 11199K | Eribulin Dr.Reddy's, RZ – ERIBULIN, eribulin mesilate 1 mg/2 mL injection, 2 mL vial |
| 7255W | Pemetrexed-AFT, AE – PEMETREXED, pemetrexed 100 mg injection, 1 vial |
| 7255W | Pemetrexed-AFT, AE – PEMETREXED, pemetrexed 500 mg injection, 1 vial |
Alterations
Alteration – Note
| 15066Y |
DARATUMUMAB, daratumumab 100 mg/5 mL injection, 5 mL vial (Darzalex); daratumumab 400 mg/20 mL injection, 20 mL vial (Darzalex) |
| 15093J |
DARATUMUMAB, daratumumab 100 mg/5 mL injection, 5 mL vial (Darzalex); daratumumab 400 mg/20 mL injection, 20 mL vial (Darzalex) |
| 15094K |
DARATUMUMAB, daratumumab 100 mg/5 mL injection, 5 mL vial (Darzalex); daratumumab 400 mg/20 mL injection, 20 mL vial (Darzalex) |
Alteration – Restriction
| 15093J |
DARATUMUMAB, daratumumab 100 mg/5 mL injection, 5 mL vial (Darzalex); daratumumab 400 mg/20 mL injection, 20 mL vial (Darzalex) |
| 15094K |
DARATUMUMAB, daratumumab 100 mg/5 mL injection, 5 mL vial (Darzalex); daratumumab 400 mg/20 mL injection, 20 mL vial (Darzalex) |
Advance Notices
1 January 2026
Deletion – Brand
| 10158P | DBL Docetaxel Concentrated Injection, PF – DOCETAXEL, docetaxel 80 mg/8 mL injection, 8 mL vial |
| 10158P | DBL Docetaxel Concentrated Injection, PF – DOCETAXEL, docetaxel 160 mg/16 mL injection, 16 mL vial |
Efficient Funding of Chemotherapy (Public Hospital)
Additions
Addition – Item
| 15125C |
TORIPALIMAB, Toripalimab 240 mg/6 mL injection, 6 mL vial (Zytorvi) |
Addition – Brand
| 10144X | Eribulin Dr.Reddy's, RZ – ERIBULIN, eribulin mesilate 1 mg/2 mL injection, 2 mL vial |
| 11212D | Eribulin Dr.Reddy's, RZ – ERIBULIN, eribulin mesilate 1 mg/2 mL injection, 2 mL vial |
| 4600D | Pemetrexed-AFT, AE – PEMETREXED, pemetrexed 100 mg injection, 1 vial |
| 4600D | Pemetrexed-AFT, AE – PEMETREXED, pemetrexed 500 mg injection, 1 vial |
Alterations
Alteration – Note
| 15065X |
DARATUMUMAB, daratumumab 100 mg/5 mL injection, 5 mL vial (Darzalex); daratumumab 400 mg/20 mL injection, 20 mL vial (Darzalex) |
| 15072G |
DARATUMUMAB, daratumumab 100 mg/5 mL injection, 5 mL vial (Darzalex); daratumumab 400 mg/20 mL injection, 20 mL vial (Darzalex) |
| 15077M |
DARATUMUMAB, daratumumab 100 mg/5 mL injection, 5 mL vial (Darzalex); daratumumab 400 mg/20 mL injection, 20 mL vial (Darzalex) |
Alteration – Restriction
| 15065X |
DARATUMUMAB, daratumumab 100 mg/5 mL injection, 5 mL vial (Darzalex); daratumumab 400 mg/20 mL injection, 20 mL vial (Darzalex) |
| 15077M |
DARATUMUMAB, daratumumab 100 mg/5 mL injection, 5 mL vial (Darzalex); daratumumab 400 mg/20 mL injection, 20 mL vial (Darzalex) |
Advance Notices
1 January 2026
Deletion – Brand
| 10148D | DBL Docetaxel Concentrated Injection, PF – DOCETAXEL, docetaxel 80 mg/8 mL injection, 8 mL vial |
| 10148D | DBL Docetaxel Concentrated Injection, PF – DOCETAXEL, docetaxel 160 mg/16 mL injection, 16 mL vial |
Related Pharmaceutical Benefits for Public Hospital use
Additions
Addition – Item
| 5890B | FOLINIC ACID, folinic acid 50 mg/5 mL injection, 5 mL vial (DBL Leucovorin Calcium) |
Addition – Brand
| 5848T | ONDANSETRON-AFT, AE – ONDANSETRON, ondansetron 4 mg/5 mL oral liquid, 50 mL |
Addition – Equivalence Indicator
| 1899Y | Leucovorin Calcium (Pfizer Australia Pty Ltd), PF – FOLINIC ACID, folinic acid 50 mg/5 mL injection, 10 x 5 mL ampoules |
| 5848T | Zofran syrup 50 mL, AS – ONDANSETRON, ondansetron 4 mg/5 mL oral liquid, 50 mL |
Addition – Note
| 1899Y | FOLINIC ACID, folinic acid 50 mg/5 mL injection, 10 x 5 mL ampoules (Leucovorin Calcium (Pfizer Australia Pty Ltd)) |
Alterations
Alteration – Note
| 15083W | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |
| 15092H | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |
| 15102W | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |
Alteration – Restriction
| 15092H | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |
| 15102W | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |
Alteration – Number of Repeats
| From | To | ||
| 15092H | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) | 7 | 15 |
